{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T06:49:15Z","timestamp":1776581355272,"version":"3.51.2"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,12,21]],"date-time":"2003-12-21T00:00:00Z","timestamp":1071964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1038\/nm972","type":"journal-article","created":{"date-parts":[[2003,12,31]],"date-time":"2003-12-31T17:59:01Z","timestamp":1072893541000},"page":"33-39","source":"Crossref","is-referenced-by-count":1940,"title":["Molecular determinants of resistance to antiandrogen therapy"],"prefix":"10.1038","volume":"10","author":[{"given":"Charlie D","family":"Chen","sequence":"first","affiliation":[]},{"given":"Derek S","family":"Welsbie","sequence":"additional","affiliation":[]},{"given":"Chris","family":"Tran","sequence":"additional","affiliation":[]},{"given":"Sung Hee","family":"Baek","sequence":"additional","affiliation":[]},{"given":"Randy","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Robert","family":"Vessella","sequence":"additional","affiliation":[]},{"given":"Michael G","family":"Rosenfeld","sequence":"additional","affiliation":[]},{"given":"Charles L","family":"Sawyers","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2003,12,21]]},"reference":[{"key":"BFnm972_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/35094009","volume":"1","author":"BJ Feldman","year":"2001","unstructured":"Feldman, B.J. & Feldman, D. The development of androgen-independent prostate cancer. Nat. Rev. Cancer 1, 34\u201345 (2001).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm972_CR2","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1200\/JCO.2002.10.018","volume":"20","author":"EP Gelmann","year":"2002","unstructured":"Gelmann, E.P. Molecular biology of the androgen receptor. J. Clin. Oncol. 20, 3001\u20133015 (2002).","journal-title":"J. Clin. Oncol."},{"key":"BFnm972_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0090-4295(02)01593-5","volume":"60","author":"SP Balk","year":"2002","unstructured":"Balk, S.P. Androgen receptor as a target in androgen-independent prostate cancer. Urology 60, 132\u2013138 (2002).","journal-title":"Urology"},{"key":"BFnm972_CR4","first-page":"2511","volume":"59","author":"ME Taplin","year":"1999","unstructured":"Taplin, M.E. et al. Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist. Cancer Res. 59, 2511\u20132515 (1999).","journal-title":"Cancer Res."},{"key":"BFnm972_CR5","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1200\/JCO.2003.11.102","volume":"21","author":"ME Taplin","year":"2003","unstructured":"Taplin, M.E. et al. Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663. J. Clin. Oncol. 21, 2673\u20132678 (2003).","journal-title":"J. Clin. Oncol."},{"key":"BFnm972_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/ng0495-401","volume":"9","author":"T Visakorpi","year":"1995","unstructured":"Visakorpi, T. et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat. Genet. 9, 401\u2013406 (1995).","journal-title":"Nat. Genet."},{"key":"BFnm972_CR7","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJM199505253322101","volume":"332","author":"ME Taplin","year":"1995","unstructured":"Taplin, M.E. et al. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N. Engl. J. Med. 332, 1393\u20131398 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnm972_CR8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0006-291X(05)80067-1","volume":"173","author":"J Veldscholte","year":"1990","unstructured":"Veldscholte, J. et al. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem. Biophys. Res. Commun. 173, 534\u2013540 (1990).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm972_CR9","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1021\/jm011072j","volume":"45","author":"PM Matias","year":"2002","unstructured":"Matias, P.M. et al. Structural basis for the glucocorticoid response in a mutant human androgen receptor (AR(ccr)) derived from an androgen-independent prostate cancer. J. Med. Chem. 45, 1439\u20131446 (2002).","journal-title":"J. Med. Chem."},{"key":"BFnm972_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/6495","volume":"5","author":"N Craft","year":"1999","unstructured":"Craft, N., Shostak, Y., Carey, M. & Sawyers, C.L. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2\/neu tyrosine kinase. Nat. Med. 5, 280\u2013285 (1999).","journal-title":"Nat. Med."},{"key":"BFnm972_CR11","doi-asserted-by":"publisher","first-page":"29304","DOI":"10.1074\/jbc.M204131200","volume":"277","author":"D Gioeli","year":"2002","unstructured":"Gioeli, D. et al. Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J. Biol. Chem. 277, 29304\u201329314 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnm972_CR12","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1126\/science.270.5241.1491","volume":"270","author":"S Kato","year":"1995","unstructured":"Kato, S. et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270, 1491\u20131494 (1995).","journal-title":"Science"},{"key":"BFnm972_CR13","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1128\/MCB.20.14.5041-5047.2000","volume":"20","author":"J Font de Mora","year":"2000","unstructured":"Font de Mora, J. & Brown, M. AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol. Cell. Biol. 20, 5041\u20135047 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm972_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S1097-2765(00)80479-7","volume":"3","author":"A Tremblay","year":"1999","unstructured":"Tremblay, A., Tremblay, G.B., Labrie, F. & Giguere, V. Ligand-independent recruitment of SRC-1 to estrogen receptor \u03b2 through phosphorylation of activation function AF-1. Mol. Cell 3, 513\u2013519 (1999).","journal-title":"Mol. Cell"},{"key":"BFnm972_CR15","first-page":"4315","volume":"61","author":"CW Gregory","year":"2001","unstructured":"Gregory, C.W. et al. A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res. 61, 4315\u20134319 (2001).","journal-title":"Cancer Res."},{"key":"BFnm972_CR16","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0002-9440(10)64422-7","volume":"161","author":"P Li","year":"2002","unstructured":"Li, P. et al. Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer. Am. J. Pathol. 161, 1467\u20131474 (2002).","journal-title":"Am. J. Pathol."},{"key":"BFnm972_CR17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1101\/gad.14.2.121","volume":"14","author":"CK Glass","year":"2000","unstructured":"Glass, C.K. & Rosenfeld, M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14, 121\u2013141 (2000).","journal-title":"Genes Dev."},{"key":"BFnm972_CR18","first-page":"4438","volume":"55","author":"AJ Raffo","year":"1995","unstructured":"Raffo, A.J. et al. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res. 55, 4438\u20134445 (1995).","journal-title":"Cancer Res."},{"key":"BFnm972_CR19","first-page":"6940","volume":"52","author":"TJ McDonnell","year":"1992","unstructured":"McDonnell, T.J. et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 52, 6940\u20136944 (1992).","journal-title":"Cancer Res."},{"key":"BFnm972_CR20","first-page":"3623","volume":"60","author":"H Kinoshita","year":"2000","unstructured":"Kinoshita, H. et al. Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. Cancer Res. 60, 3623\u20133630 (2000).","journal-title":"Cancer Res."},{"key":"BFnm972_CR21","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1097-2765(02)00471-9","volume":"9","author":"Y Shang","year":"2002","unstructured":"Shang, Y., Myers, M. & Brown, M. Formation of the androgen receptor transcription complex. Mol. Cell 9, 601\u2013610 (2002).","journal-title":"Mol. Cell"},{"key":"BFnm972_CR22","doi-asserted-by":"publisher","first-page":"15152","DOI":"10.1073\/pnas.93.26.15152","volume":"93","author":"HY Zhau","year":"1996","unstructured":"Zhau, H.Y. et al. Androgen-repressed phenotype in human prostate cancer. Proc. Natl. Acad. Sci. USA 93, 15152\u201315157 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm972_CR23","first-page":"6049","volume":"54","author":"MA Wainstein","year":"1994","unstructured":"Wainstein, M.A. et al. CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. Cancer Res. 54, 6049\u20136052 (1994).","journal-title":"Cancer Res."},{"key":"BFnm972_CR24","first-page":"1039","volume":"2","author":"WJ Ellis","year":"1996","unstructured":"Ellis, W.J. et al. Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23. Clin. Cancer Res. 2, 1039\u20131048 (1996).","journal-title":"Clin. Cancer Res."},{"key":"BFnm972_CR25","first-page":"1809","volume":"43","author":"JS Horoszewicz","year":"1983","unstructured":"Horoszewicz, J.S. et al. LNCaP model of human prostatic carcinoma. Cancer Res. 43, 1809\u20131818 (1983).","journal-title":"Cancer Res."},{"key":"BFnm972_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nm0497-402","volume":"3","author":"KA Klein","year":"1997","unstructured":"Klein, K.A. et al. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat. Med. 3, 402\u2013408 (1997).","journal-title":"Nat. Med."},{"key":"BFnm972_CR27","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou, C.M. et al. Molecular portraits of human breast tumours. Nature 406, 747\u2013752 (2000).","journal-title":"Nature"},{"key":"BFnm972_CR28","first-page":"2892","volume":"61","author":"CW Gregory","year":"2001","unstructured":"Gregory, C.W., Johnson, R.T., Jr., Mohler, J.L., French, F.S. & Wilson, E.M. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Cancer Res. 61, 2892\u20132898 (2001).","journal-title":"Cancer Res."},{"key":"BFnm972_CR29","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1210\/mend.16.5.0829","volume":"16","author":"ZQ Huang","year":"2002","unstructured":"Huang, Z.Q., Li, J. & Wong, J. AR possesses an intrinsic hormone-independent transcriptional activity. Mol. Endocrinol. 16, 924\u2013937 (2002).","journal-title":"Mol. Endocrinol."},{"key":"BFnm972_CR30","doi-asserted-by":"publisher","first-page":"26164","DOI":"10.1074\/jbc.M004571200","volume":"275","author":"PM Matias","year":"2000","unstructured":"Matias, P.M. et al. Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. J. Biol. Chem. 275, 26164\u201326171 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnm972_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0303-7207(95)03709-8","volume":"116","author":"JM Lobaccaro","year":"1996","unstructured":"Lobaccaro, J.M. et al. Molecular modeling and in vitro investigations of the human androgen receptor DNA-binding domain: application for the study of two mutations. Mol. Cell. Endocrinol. 116, 137\u2013147 (1996).","journal-title":"Mol. Cell. Endocrinol."},{"key":"BFnm972_CR32","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.1093\/emboj\/19.20.5406","volume":"19","author":"A Migliaccio","year":"2000","unstructured":"Migliaccio, A. et al. Steroid-induced androgen receptor-oestradiol receptor \u03b2-Src complex triggers prostate cancer cell proliferation. EMBO J. 19, 5406\u20135417 (2000).","journal-title":"EMBO J."},{"key":"BFnm972_CR33","first-page":"719","volume":"104","author":"S Kousteni","year":"2001","unstructured":"Kousteni, S. et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104, 719\u2013730 (2001).","journal-title":"Cell"},{"key":"BFnm972_CR34","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1210\/rp.57.1.385","volume":"57","author":"SC Manolagas","year":"2002","unstructured":"Manolagas, S.C., Kousteni, S. & Jilka, R.L. Sex steroids and bone. Recent Prog. Horm. Res. 57, 385\u2013409 (2002).","journal-title":"Recent Prog. Horm. Res."},{"key":"BFnm972_CR35","doi-asserted-by":"publisher","first-page":"RESEARCH0032","DOI":"10.1186\/gb-2002-3-7-research0032","volume":"3","author":"SE DePrimo","year":"2002","unstructured":"DePrimo, S.E. et al. Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol. 3, RESEARCH0032 (2002).","journal-title":"Genome Biol."},{"key":"BFnm972_CR36","doi-asserted-by":"publisher","first-page":"26321","DOI":"10.1074\/jbc.M203310200","volume":"277","author":"D Masiello","year":"2002","unstructured":"Masiello, D., Cheng, S., Bubley, G.J., Lu, M.L. & Balk, S.P. Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor. J. Biol. Chem. 277, 26321\u201326326 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnm972_CR37","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/sj.bjc.6601127","volume":"89","author":"J Edwards","year":"2003","unstructured":"Edwards, J., Krishna, N.S., Grigor, K.M. & Bartlett, J.M. Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer. Br. J. Cancer 89, 552\u2013556 (2003).","journal-title":"Br. J. Cancer"},{"key":"BFnm972_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/gcc.10097","volume":"35","author":"S Laitinen","year":"2002","unstructured":"Laitinen, S., Karhu, R., Sawyers, C.L., Vessella, R.L. & Visakorpi, T. Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization. Genes Chromosomes Cancer 35, 66\u201373 (2002).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnm972_CR39","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1210\/mend.13.11.0369","volume":"13","author":"JM Grad","year":"1999","unstructured":"Grad, J.M., Dai, J.L., Wu, S. & Burnstein, K.L. Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen-mediated up-regulation of AR messenger RNA. Mol. Endocrinol. 13, 1896\u20131911 (1999).","journal-title":"Mol. Endocrinol."},{"key":"BFnm972_CR40","first-page":"5030","volume":"59","author":"N Craft","year":"1999","unstructured":"Craft, N. et al. Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process. Cancer Res. 59, 5030\u20135036 (1999).","journal-title":"Cancer Res."},{"key":"BFnm972_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1535-6108(03)00197-1","volume":"4","author":"K Ellwood-Yen","year":"2003","unstructured":"Ellwood-Yen, K. et al. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4, 223\u2013238 (2003).","journal-title":"Cancer Cell"},{"key":"BFnm972_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1535-6108(03)00215-0","volume":"4","author":"S Wang","year":"2003","unstructured":"Wang, S. et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4, 209\u2013221 (2003).","journal-title":"Cancer Cell"},{"key":"BFnm972_CR43","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0092-8674(00)81717-1","volume":"95","author":"AK Shiau","year":"1998","unstructured":"Shiau, A.K. et al. The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95, 927\u2013937 (1998).","journal-title":"Cell"},{"key":"BFnm972_CR44","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1126\/science.285.5428.744","volume":"285","author":"JD Norris","year":"1999","unstructured":"Norris, J.D. et al. Peptide antagonists of the human estrogen receptor. Science 285, 744\u2013746 (1999).","journal-title":"Science"},{"key":"BFnm972_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0092-8674(02)00809-7","volume":"110","author":"SH Baek","year":"2002","unstructured":"Baek, S.H. et al. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-\u03baB and \u03b2-amyloid precursor protein. Cell 110, 55\u201367 (2002).","journal-title":"Cell"},{"key":"BFnm972_CR46","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1126\/science.1068537","volume":"295","author":"Y Shang","year":"2002","unstructured":"Shang, Y. & Brown, M. Molecular determinants for the tissue specificity of SERMs. Science 295, 2465\u20132468 (2002).","journal-title":"Science"},{"key":"BFnm972_CR47","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0022-5347(01)64846-8","volume":"157","author":"PF Schellhammer","year":"1997","unstructured":"Schellhammer, P.F. et al. Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockade. J. Urol. 157, 1731\u20131735 (1997).","journal-title":"J. Urol."},{"key":"BFnm972_CR48","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.1073\/pnas.081565498","volume":"98","author":"JS Sack","year":"2001","unstructured":"Sack, J.S. et al. Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc. Natl. Acad. Sci. USA 98, 4904\u20134909 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm972_CR49","doi-asserted-by":"crossref","first-page":"13115","DOI":"10.1016\/S0021-9258(17)36806-0","volume":"269","author":"ZX Zhou","year":"1994","unstructured":"Zhou, Z.X., Sar, M., Simental, J.A., Lane, M.V. & Wilson, E.M. A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences. J. Biol. Chem. 269, 13115\u201313123 (1994).","journal-title":"J. Biol. Chem."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm972.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm972","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm972.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:36:00Z","timestamp":1684449360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,21]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["BFnm972"],"URL":"https:\/\/doi.org\/10.1038\/nm972","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12,21]]}}}